Skip to content
Screener
Aktis Oncology, Inc. logo

Aktis Oncology, Inc.

AKTS

Aktis Oncology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Roden, with a market cap of $910.5M.

Market cap
$910.49M-16.7%

We’re still putting together Aktis Oncology, Inc.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Aktis Oncology, Inc. up the queue, and we’ll analyze its filings next.

Earnings

Next report

Date not yet announced

Profile

Listed2026
Employees79.0
CEOMatthew Roden
FilingsSEC EDGAR